Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.

By P. Thavendiranathan, F. Poulin, Ki-Dong Lim, J. Plana, A. Woo, T. Marwick. Journal of the American College of Cardiology, 2014

1,053 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging

View Paper: https://www.semanticscholar.org/paper/e244ca5de9ab1b0c266ada1ee5bad7be5c001b43

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

In Radiology, Nuclear Medicine and Imaging

Citations in the corpus

Assessment of Left Ventricular Function by Echocardiography: The Case for Routinely Adding Global Longitudinal Strain to Ejection Fraction. (2018, background): “relative change in GLS early in treatment predictive of subsequent EF reduction (34).”
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations (2020, background): “Early indicators of LV systolic dysfunction (LVSD) such as GLS may be useful for identifying patients at risk of anthracycline-based cardiotoxicity before the development of HF.(97) Studies have consistently shown significant GLS reductions in patients at cumulative doses of doxorubicin as low as 10”
Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. (2014, background): “A recent systematic review shows that as of 2014, 21 peerreviewed studies have reported the sensitivity of measuring deformation indices (strain, strain rate, and twist) in the detection of subclinical LV dysfunction in patients treated for cancer (Table 4 summarizes these studies).(157) The studies”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines (2016, background): “4 Patients with asymptomatic reduction in global longitudinal strain during chemotherapy Currently there is no evidence to guide specific cardioprotection if early signs of subclinical myocardial dysfunction are detected during echocardiography-based GLS surveillance.(85,90,250) GLS may be a more se”
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, background): “4 Patients with asymptomatic reduction in global longitudinal strain during chemotherapy Currently there is no evidence to guide specific cardioprotection if early signs of subclinical myocardial dysfunction are detected during echocardiography-based GLS surveillance.(85,90,250) GLS may be a more se”